1. Бутрова С.А. Ожирение. Глава 2. Метаболический синдром. М., 2004; 44–6.
2. Вознесенская Т.Г. Церебральное ожирение и истощение (клиническое, нейроэндокринологическое и психофизиологическое исследование). Дисс. ... д-ра мед. наук. М., 1990.
3. Вознесенская Т.Г. Ожирение. Глава 9. Типология нарушений ПП и эмоционально-личностные расстройства при первичном ожирении и их коррекция. М., 2004; 236–56.
4. Вознесенская Т.Г. Расстройства пищевого поведения при ожирении и их коррекция. Ожирение и метаболизм. 2004; 2: 1–4.
5. Вознесенская Т.Г., Вахмистров А.В. Клинико-психологический анализ нарушений пищевого поведения при ожирении. Журн. неврол. и психиатр. 2001; 12: 19–24.
6. Гинзбург М.М., Крюков Н.Н. Ожирение. 2002; 53–76.
7. Дедов И.И., Мельниченко Г.А. Ожирение. 2004; 8, 44–73, 234–266.
8. Дэниел Г. Бессен, Роберт Кушнер. Избыточный вес и ожирение. М., 2004; 196–207.
9. Звенигородская Л.А., Кучеренко Т.В. Типы пищевого поведения и гормоны пищевого поведения у больных с метаболическим синдромом. Экспер. и клин. гастроэнтнрол. 2007; 1: 24–7.
10. Кассиль В.Г. Пищевое поведение в онтогенезе. Л., 1990; 132–45.
11. Манцорос Х.С. Современные представления о роли лептина в развитии ожирения и связанных с ним заболеваний человека. Междун. журн. мед. практ. 2000; 9: 57–67.
12. МКБ Х. Раздел Y. Психические расстройства в общей медицинской практике. ВОЗ, 1996.
13. Селиванова А.В., Ракова Н.Г., Федорова М.М. Ожирение и сахарный диабет. Лаборатория. 2005; 1: 12–5.
14. Abizaid A, Lui ZB, Andrews ZB. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 2006; 116: 3229–39.
15. Allon B. The stigma of overweight in everyday life: obesiti in perspective. Ed. G.A.Gray. Washington: Fogarta Internat. Cent. Series Prevent. Med. 1973; 2 (2): 83–102.
16. Altman J. Weight in the balance. Neurjendocr 2002; 76: 6–131.
17. Barrachina MD, Martinez V, Wang L et al. Synergistic interaction between leptin and cholecystokinin term food intake in lean mice. J List 1997; 94 (19): 10455–60.
18. Cota D, Tschop MH. Cannabinoids, opioids and eating beh * avior: the molecular face of hedonism? Brain Res Rev 2006; 51: 85–107.
19. Cowley MA, Smith RG, Diano S et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003; 37: 649–61.
20. Cummings DE. Plasma ghrelin levels after diet – induced weight loss or gastric by pass surgery. N Engl J Med 2002; 346: 1623–30.
21. Cummings D. E., Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007; 117 (1): 13–23.
22. Date Y, Kojima M, Nosoda H et al. Ghrelin, a novel growth hormone – releasing acilated peptide, is synthesized in distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255–61.
23. Date Y, Nakazato M, Murakami N et al. Ghrelin acts in the CNS to stimulate gastric acid secretion. Biochem Biophis Res Commu 2001; 280: 904–7.
24. Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance. Nat Neurosci 2005; 8: 585–9.
25. Dixit VD, Schaffer EM, Pyle RS. Ghrelin ingibits leptin and activation induced proinflammatory cytokine expression by human monocytes and T-cells. J Clin Invest 2004; 114: 57–66.
26. Drucker DJ. The biology of incretin hormones. Cell Metab 2006; 3: 153–65.
27. Engeli S, Bohnke J, Feldpausch M. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 2005; 54: 2838–43.
28. Grove KL, Cowley MA. Is ghrelin a signal for the development of metabolic systems? J Clin Invest 115; 3393–7.
29. Hagg A, Hoch A, Geler F. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocr 2003; 88: 174–8.
30. Kojima M, Nosoda H, Date Y. Ghrelin is a growth hormone releasing acylated peptide from stomach. Nature 1999; 402: 656–60.
31. Mackie K. Cannabinoid receptors as therapeutic targets. – Annu Rev Pharmacol Toxicol. 2006; 46; 101–22.
32. Matson CA, Reid DF, Cannon TA, Ritter RC. Cholecystokinin and leptin act synergitically to reduce body weight. Am J Psysiol 2000; 278: 1275–78.
33. Monteleone P, Matias I, Martiadis V. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 2005; 30: 1216–21.
34. Nakazato M, Murakami N, Date Y et al. A role for ghrelin in central regulation of feeding. Nature 2001; 409: 194–8.
35. Popovic V, Miljic D, Micic D. Ghrelin main action on the regulation of growth gormone release is exerted at hypotalamic level. J Clin Endocrin Metabol 2003; 88: 3450–3.
36. Reaven GM. Banting Lecture: role of insulin resistence in human disease. Diabetes 1988; 37: 607–1595.
37. Richard W. Nesto, Ken Mackie. Endocannabinoid system end its implications for obesity and cardiometabolic risk. Eur. Heart Suppl 2008; 10: B34–41.
38. Ritter RC. Gastrointestinal mechanisms of satiation for food. Physiol. Behav. 2004; 84: 249–37.
39. Rozin P. Towards a Psychology of food choice. Institut Danone 1998.
40. Sipe J, Waalen J, Gerber A, Beutler E. Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase(FAAH). Int J Obes Relat Metab Disord 2005; 29: 755–9.
41. Strader AD, Woods SC. Gastrointestinal hormones and food intake. – Gastroenterologi 2005; 128: 175–91.
42. Takaya K, Ariyasu H, Kanamoto N. Ghrelin strongli stimulates growth hormone(GH) release in humans. J Clin Endocr Metab 2000; 85: 4908–11.
43. Theander-Carrillo C, Wiedmer P, Cettour-Rose P et al. Ghrelin action in brain controls adipocyne metabolism. J Clin Invest 2006; 116: 1983–93.
44. Tsunoda Y, Yao H, Park J, Owyang C. Cholecystokinin synthesizes and secretes leptin in isolated canine gastric chief cells. Biochem Biophys Res Commun 2003; 310: 681–4.
45. Unger RH, Orsi L. Diseases of liporegulation: new perspective on obesiti and related disorders. FASEBJ 2001; 15: 21–312.
46. Unger RH. Lipotoxic Diseases. Annu Rev Med 2002; 53: 36–319.
47. Van Strien T et al. The Dutch eating behavior questionnaire (DEBQ) for assessment of restraind, emotional and external eating behavior. Int J Eating Disord 1986; 2: 188–204.
48. Yalniz M, Bahcecioglu IH, Ataseven H. Serum adipokine and ghrelin levels in nonalcogolic steatohepatites. Mediat. Inflammat 2006; 6: 34295.